Purpose: To investigate the use of sirolimus-eluting biodegradable stents (SEBSs) to suppress granulation tissue formation after stent placement in a rat urethral model. Materials and Methods: All experiments were approved by the animal research committee. A total of 36 male Sprague-Dawley rats were randomized into three equal groups after biodegradable stent placement. Group A received control biodegradable stents. Groups B and C received stents coated with 90 μg/cm2 and 450 μg/cm2 sirolimus, respectively. Six rats in each group were sacrificed after 4 weeks; the remaining rats were sacrificed after 12 weeks. The therapeutic effectiveness of SEBSs was assessed by comparing the results of retrograde urethrography and histologic examination. Analysis of variance with post hoc comparisons was used to evaluate statistical differences. Results: SEBS placement was technically successful in all rats. Urethrographic and histologic examinations revealed significantly less granulation tissue formation at both time points in the rats receiving SEBSs (groups B and C) compared with those that received control stents (group A) (P <.05 for all). There were no significant differences in urethrographic and histologic findings between groups B and C (P = .05 for all). However<the mean number of epithelial layers in group B was higher than that in group C at 4 weeks after stent placement (P <.001). Apoptosis increased in group C compared with groups A and B (P <.05 for all). Conclusion: The use of SEBSs suppressed granulation tissue formation secondary to stent placement in a rat urethral model; local therapy with SEBSs may be used to decrease stentrelated granulation tissue formation.
ASJC Scopus subject areas
- Radiology Nuclear Medicine and imaging